Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Food and Drug Administration (FDA) for the treatment of type 2 diabetes
About the Company : Inabata France, established in 1990 and part of the Inabata Group, acquired Pharmasynthse in 2006
1 Glucagon-like peptide-1 agonists (GLP-1), popular choices for the second-line treatment of type 2 diabetes and, most recently, obesity, are connected with DR
Start a new chapter in self-care
Family members and caregivers should be trained to administer glucagon via injection (Gvoke, Zegalogue) or nasal spray (Baqsimi) if the patient is unconscious or unable to swallow safely
US$ 29.18
US$ 26.46
US$ 20.16
US$ 24.12
